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ALIMENTARY TRACT
Do opioid receptors play a role in the pathogenesis of the inflammatory response in acute 
pancreatitis?1
Os receptores opioides desempenham papel na patogênese da resposta inflamatória na 
pancreatite aguda?
Artur PenidoI, Ana Maria Mendonça CoelhoII, Nilza Trindade MolanIII, Fabiano Pinheiro da SilvaIV, Luiz Augusto Carneiro 
D’AlbuquerqueV, Marcel Cerqueira Cesar MachadoVI
IGraduate student, School of Medicine, Alfenas University (UNIFENAS), MG, Brazil. Invoved in technical procedures and acquisition of data.
IIPhD, Laboratory of Liver Transplantation and Experimental Surgery (LIM/37), Department of Gastroenterology, Medical School, USP, Sao Paulo, 
Brazil. Performed biochemical analysis and statistical evaluation.
IIIBSc, Laboratory of Liver Transplantation and Experimental Surgery (LIM/37), Department of Gastroenterology, Medical School, USP, Sao Paulo, 
Brazil. Performed sample collections and biochemical analysis.
IVPhD, Laboratory of Emergency Medicine (LIM/51), Department of Medical Clinic, Medical School, USP, Sao Paulo, Brazil. Revised the manuscript.
V MD, PhD, Chairman and Head, Digestive Tract Transplantantion Division, Department of Gastroenterology, Medical School, University of São 
Paulo, São Paulo, Brazil. Manuscript revision.
VIPhD, Emeritus Professor of Surgery, Laboratory of Emergency Medicine (LIM/51), Department of Medical Clinic, Medical School, USP, Sao Paulo, 
Brazil. Analysis and interpretation of data, manuscript writing.
ABSTRACT
PURPOSE: To investigate the effect of the opioid blocker naltrexone in the inflammatory response in acute pancreatitis (AP).
METHODS: Acute pancreatitis was induced in anesthetized male Wistar rats by retrograde injection of 2.5% sodium taurocholate 
diluted in 0.5ml saline into the main pancreatic duct. Animals were randomized to the following experimental groups: Control Group 
(n=9): animals received an intraperitoneal injection of saline solution (0.5ml), 15 minutes before the induction of AP. Naltrexone Group 
(n=9): animals received an intraperitoneal injection of naltrexone 0.5ml (15 mg/kg), 15 minutes before induction of AP. Peritoneal levels 
of TNF-α and serum levels of IL-6 and amylase were determined The volume of the ascitic fluid was also evaluated. Myeloperoxidase 
(MPO) activities were analyzed in homogenates of pulmonary tissue.
RESULTS: There were no significant differences in the ascitic fluid volume, nor in TNF-a and IL-6 levels in the naltrexone group 
compared to controls. Treatment with naltrexone did not affect the lung MPO activity compared to control group. 
CONCLUSIONS: The opioid receptors don’t play an important role in the pathogenesis of the inflammatory response in acute 
pancreatitis. If opioids affect leukocytes inflammatory signaling, there are no major implications in the pathogenesis of acute pancreatitis.
Key words: Pancreatitis. Physiopathology. Receptors, Opioid. Naltrexone. Rats.
RESUMO
OBJETIVO: Investigar o efeito do bloqueador opióide naltrexone na resposta inflamatória da pancreatite aguda.
METODOS: Pancreatite aguda foi induzida em ratos machos Wistar, através de injeção retrógada de solução de taurocolato de sódio a 
2,5% nos ductos pancreáticos. Os animais foram alocados em dois grupos: Grupo controle (n=9) animais receberam 0,5 ml de solução 
salina intra-peritonial 15 minutos antes da indução da pancreatite aguda e Grupo naltrexone (n=9) animais receberam naltrexone (15mg/
kg de peso), em 0,5 ml de volume final por via intraperitoneal, 15 minutos antes da indução da pancreatite aguda. Foram avaliados o 
volume de ascite, os níveis séricos de amilase e IL-6, assim como TNF-α peritoneal e a atividade da mieloperoxidase (MPO) no tecido 
pulmonar.
RESULTADOS: Não foram encontradas diferenças significantes nos parâmetros analisados entre o grupo que recebeu solução salina 
e o que recebeu naltrexone .
CONCLUSÕES: Os receptores opióides não desempenham papel importante na resposta inflamatória sistêmica associada à pancreatite 
aguda. Se os opioides alteram a sinalização inflamatória nos leucócitos está ação não se reflete na patogênese da pancreatite aguda
Descritores: Pancreatite. Fisiopatologia. Receptores Opióides. Naltrexona. Ratos.
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Introduction
 
The opioid receptor family consists of the µ(MOR), 
δ(DOR) and κ (KOR) receptors, belonging to the family of seven 
transmembrane G-nucleotide binding protein-coupled receptors. 
They are found in the central nervous system and in peripheral 
neurons.
Immune cells also express opioid binding sites 
and modulation of immune functions (chemotaxis, cytokine 
production, degranulation, etc) by opioids have been reported1. 
Studies have also shown that immune cells play a role in the control 
of inflammatory pain, by the production of endogenous opioid 
peptides that accumulate in the inflamed tissue. Many substances 
(corticotrophin releasing factor, cytokines, catecholamines), as 
well as environmental factors (psychological stress, for example) 
can liberate these substances. These effects can be aborted by 
opioid receptor antagonists.
Endogenous opioids derived from immune cells, as 
α- and β-endorphin, dynorphin A and B, α- and β-neoendorphin 
and enkephalins produce potent analgesia. These molecules 
are the natural ligands for MOR, DOR and KOR. In the early 
phase of inflammation, most endogenous opioids are produced 
by granulocytes. Later, monocytes become the main source2. 
Exogenous opioids, however, are largely used in medicine to treat 
pain, in diseases such as acute pancreatitis.
Acute pancreatitis (AP) is an inflammation of varying 
severity, accounting for 210.000 cases per year in the U.S. or 
50 cases per 100.000 inhabitants. It is due to intraparenchymal 
activation of pancreatic enzymes and is characterized by elevation 
of serum pancreatic enzymes, including: amylase, lipase, trypsin, 
cathepsin B, among others3.
The injury of the pancreatic parenchyma results in leakage 
and activation of pancreatic enzymes in the interstitium. Activated 
enzymes also leak to peripancreatic tissues, the peritoneal 
cavity and the systemic circulation. The inflammatory process 
results both from local and systemic activation of inflammatory 
cells, with cytokine production not only in pancreatic tissue and 
peripancreatic areas, but also in many distant tissues. Tryptolytic 
pancreatic enzymes into the peritoneal cavity stimulate resident 
macrophages to produce cytokines that fall into the systemic 
circulation and contribute to the systemic inflammatory response4.
During inflammation, numerous mediators are produced 
by endothelial cells, leukocytes and others, that elicit pain by 
activation of nocireceptors.
The severity of AP is related to the development of a 
systemic inflammatory response syndrome (SIRS), due to high 
cytokine levels, especially interleukin IL-1β, IL-6, IL-8, Tumor 
Necrosis Factor-α (TNF-α) and NO5.
It seems obvious that reducing the levels of 
proinflammatory cytokines could reduce the deleterious effects 
of AP. Thus, various measures including anti-TNF-α, peritoneal 
lavage, pentoxifylline and hypertonic saline solution have been 
studied in order to reduce the systemic inflammatory response and, 
as a consequence, mortality6.
Naltrexone hydrochloride, which is a drug used to 
treat alcoholism, has been studied among the several drugs that 
theoretically could reduce the inflammatory process in AP. It is an 
opioid receptor antagonist, a synthetic congener of oxymorphone, 
differing in its molecular structure, because the methyl group on 
the nitrogen atom is replaced by the cyclopropylmethyl group. Its 
beneficial effect on the inflammatory process and on the expression 
of proinflammatory cytokines has been already described7,8.
Previous studies have shown a beneficial effect of 
naloxone, an analogue of naltrexone, in experimental AP, 
suggesting that endogenous opioid peptides may play an important 
role in the pathogenesis of AP9,10. In fact, Shen et al.10 showed that 
these drugs may limit the progression of the disease, especially 
from the edematous to the hemorrhagic form, suggesting that 
endogenous opioid peptides may be linked to the pathophysiology 
of AP. These authors, however, did not evaluate the effects of these 
substances on the systemic inflammatory process.
We hypothesized that opioid receptors could play a 
role in the pathogenesis of the inflammatory response in acute 
pancreatitis.
This current study aims to determine the effects of the 
opioid blocker naltrexone on the inflammatory mediators in an 
experimental model of AP.
Methods
The experimental protocol was approved by the Ethics 
Commitee for Animal Research from the Medical School of Sao 
Paulo University. All animals received care in accordance with the 
Guide for the Care and Use of Laboratory. 
Eighteen adult male Wistar rats weighing 240 to 260g, 
housed in individual cages in a 12-hour dark light-controlled 
environment, were used for the experimental protocol. Temperature 
was kept at 21 to 22oC and all rats were fed with a standard rat 
chow and ad libitum water. 
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Reagents
All chemical reagents were purchased from Sigma-
Aldrich (St. Louis, MO). TNF-α, IL-6 and IL-10 were assayed 
with corresponding kits from BioSource International (Camarillo, 
LA, Calif).
Induction of acute pancreatitis
Surgical anesthesia was induced with ketamine chloride 
50 mg/ml (0.2ml/100g body weight) (Ketalar; Parke-Davis, Sao 
Paulo, Brazil). AP was induced in anesthetized rats by retrograde 
intraductal injection of 0.5 ml of 2.5% (w/v) sodium taurocholate 
in 0.9% (w/v) NaCl into the main pancreatic duct for 1 minute at 
a constant rate using an infusion pump (KD Scientific, Holliston, 
MA). The proximal part of the hepatic duct was clamped during 
the injection11..
Experimental groups
Animals were randomized into the following 
experimental groups:
Control Group (n=9): animals received an intraperitoneal 
injection of 0.5ml saline solution, 15 minutes before induction of 
AP.
Naltrexone Group (n=9): animals received an 
intraperitoneal injection of 0.5ml naltrexone (15 mg/kg), 15 
minutes before induction of AP. 
Sample preparations 
At two hours after AP induction, animals were 
anesthetized for blood sampling through cardiac puncture and 
killed by exsanguination. Peritoneal levels of TNF-α and serum 
levels of IL-6 and amylase were assayed by a solid-phase sandwich 
enzyme-linked immune absorbent assay (ELISA). The volume 
of the ascitic fluid was also evaluated. Myeloperoxidase (MPO) 
activities were analyzed in homogenates of pulmonary tissue.
Pulmonary myeloperoxidase activity
MPO activity was used as an indicator of neutrophils 
infiltration in the tissues. Opioid peptides, moreover, are stored 
in primary granules and are released together with bactericidal 
enzymes, such as myeloperoxidase. Samples of lung tissue 
were homogenized with a Polytron homogenizer, using a 
homogenization buffer containing 0.5% of hexadecyltrimethyl 
ammonium bromide, 5 mmol/L EDTA and 50 mmol/L phosphate 
at pH 6.0. Homogenized samples were sonicated and centrifuged 
(3.000xg, 30 minutes) at 4ºC. MPO activity in the supernatant was 
assayed by measuring the change in A
460 
absorbance, resulting 
from the decomposition of H2O2 in the presence of O-dianisidine. 
Results were expressed as optical density (OD) at 460 nm12.
Statistical analysis
The groups were compared using Student’s t test and 
results are presented as mean values ± SEM. The level of p<0.05 
was considered statistically significant. The data were analyzed 
using Graphpad Prism® 4.0 software (San Diego, CA, USA).
Results
The elevated serum amylase levels found in the control 
group were not affected by naltrexone treatment (p=0.140) (Figure 
1). 
FIGURE 1 - Serum levels of amylase. AP was induced in rats by 
intraductal injection of 0.5ml of 2.5% taurocholic acid. Control group 
received saline solution administration 15 minutes before AP induction 
and Naltrexone group received naltrexone (15mg/Kg) 15 minutes before 
AP induction. Data are expressed as mean ± SEM of nine animals per 
group. 
There were no significant differences in the ascitic fluid 
volume (p=0.208), in TNF-a levels in the ascitic fluid (p=0.234) 
and in IL-6 serum levels (p=0.107) of the group control, compared 
to the naltrexone group (Figures 2A, B and C).
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FIGURE 2 - Ascitic fluid volume and Inflammatory cytokines. AP was 
induced in rats by intraductal injection of 0.5ml of 2.5% taurocholic acid. 
Control group received saline solution administration 15 minutes before 
AP induction and Naltrexone group received naltrexone (15mg/Kg) 15 
minutes before AP induction. Ascitic fluid volume (A) Concentration of 
peritoneal TNF-α (B) Serum IL-6 levels (C) Data are expressed as mean 
± SEM of nine animals per group.
Treatment with naltrexone did not affect lung MPO 
activity compared to control group (p=0.101) (Figure 3). 
FIGURE 3 - Pulmonary myeloperoxidase activity. AP was induced in rats 
by intraductal injection of 0.5ml of 2.5% taurocholic acid. Control group 
received saline solution administration 15 minutes before AP induction 
and Naltrexone group received naltrexone (15mg/Kg) 15 minutes before 
AP induction. Data are expressed as mean ± SEM of nine animals per 
group. 
Discussion
Even though in most cases AP is presented in mild or 
moderate clinical forms, in severe cases morbidity and mortality 
rates are extremely high. Several studies demonstrated that the 
severity of the disease is related to the pro-inflammatory cytokines 
liberated locally and systemically. The possibility of inhibiting 
the production of cytokines or neutralizing their effects, could 
minimize the systemic inflammatory response in AP and, therefore, 
reduce its mortality. Several experimental studies demonstrated 
that blocking the production of pro-inflammatory cytokines 
reduces the local and the systemic damage in acute pancreatitis. 
In fact, it has been demonstrated that several substances were 
effective in decreasing the pro-inflammatory cytokines in AP, 
such as pentoxifylline, oxypurinol and hypertonic solution, among 
others6.
Opioid receptors have been implicated in the 
amplification of the inflammatory process and several publications 
have proposed their implication in the pathogenesis of AP7-10.
Although opioid receptors alone do not cause 
inflammation, there is no doubt that they can stimulate lymphocytes 
and macrophages as well as cytokines production. Indeed, opioid 
receptors blockade actually reduces inflammation in chemically 
induced colitis13. In fact, naltrexone, an opioid antagonist, is able 
to block acute endotoxic shock by inhibiting TNFα production14.
Deep comprehension of the mechanisms that link opioid 
receptors and immunity are still lacking, but evidence suggests 
that the interaction of receptors of the central nervous system 
with the immune system, perhaps via the Hypothalamic-Pituitary-
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Neuroendocrine Axis or by the peripheral nerve play an important 
role15.
As already mentioned, Shen et al.10 demonstrated that the 
opioid receptor antagonist naloxone has a beneficial effect in an 
experimental model of AP in dogs, blocking the progression of the 
edematous form to the hemorrhagic form.
In the present study, although we have seen a reduction 
of the ascitic fluid with the administration of naltrexone, this 
reduction was not statistically significant (Figure 2A). There was 
even increased concentration of TNFα in the ascitic fluid with the 
use of naltrexone, without statistical significance (Figure 2B). The 
concentration of serum IL-6, although stood at levels somewhat 
lower in the naltrexone group was not statistically significant as 
well (Figure 3). The same happened with the serum amylase levels 
(Figure 1).
Lung myeloperoxidase (MPO) levels also failed to show 
any difference with the administration of naltrexone. MPO levels 
assess the systemic action of naltrexone (Figure 3).
There are no clear detrimental effects, thus, of using 
exogenous opioids to critically ill patients suffering from AP, 
other than the classic side effects (nauseas, vomiting, diarrhea, 
etc). Prolonged opioids administration, however, may lead to 
tolerance. Since some studies suggest that endogenous secretion 
of opioids may counteract opioids tolerance and peripherally 
acting opioid lack the central side effects, chemokines receptors 
agonists are under investigation as a pharmacological tool to 
stimulate the migration of opioid peptide-containing leucocytes to 
treat pain. Further studies are necessary to show if endogenous 
and exogenous opioids significantly increase the pancreatic and 
peri-pancreatic inflammatory damage and if opioid receptors 
blockers could decrease pancreatic lesion. If so, these effects have 
no implications in severe acute pancreatitis where the explosive 
systemic inflammatory response leads to injury at distant organs 
and a cytokine storm that is unresponsive to opioid receptors 
manipulation.
Conclusion
Opioid receptors don’t play an important role in the 
pathogenesis of the systemic inflammatory response in acute 
pancreatitis. 
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